Indoco Remedies, a Rs.475 crore plus Mumbai based pharma entity, has entered marketing agreement with Royal DSM N.V., for eight active pharmaceutical ingredients (APIs) and the alliance came into effect in January 2012. This marketing tie- up will leverage Indoco's product development and cGMP (current Good Manufacturing Practices) compliant manufacturing capabilities and DSM's market access. In addition DSM will use its operation and quality systems to allow faster growth in regulated markets. The Indoco alliance is anchored in DSM's API business, DSM Pharma Chemicals, headquartered in Austria.
Suresh G Kare, chairman & managing director, Indoco Remedies, commented, "Today in the era of alliances and partnerships, organizations are coming together to penetrate and capture a larger share of the potential opportunities in the market place. Indoco is active in forging such alliances and this one with DSM is a step in that direction. This alliance offers a great opportunity to expand our global presence with a well established partner like DSM."
"This is a step in our announced strategy to accelerate growth via partnerships and expansion in Asia to build a product portfolio along side our custom manufacturing operations, supplying access to high demand treatments. It allows DPP to build a competence base in India, "said Alexander Wessels, president and CEO, DSM Pharmaceutical Products (DPP).
Founded in 1947, Indoco Remedies is one of the leading manufacturers of APIs and finished dosages in India for various therapeutic classes. USDMFs (US Drug Master File), CoS (Certificate of Suitability for European Pharmacopoeia) and DMFs ( Drug Master Files) have been filed by Indoco for some products and Indoco has been seeking to expand supplies to markets across the globe, including European and US generic and branded pharmaceutical companies.
DSM was preferred for this strategic alliance by Indoco based on the strength of their long standing pharmaceutical customer contacts and presence in markets worldwide combined with their deep commitment to quality.
Indoco has a strong brand portfolio of 120 products in various therapeutic segments, including high growth life style segments such as anti-infectives, anti-diabetics, cardiovascular, ophthalmology, dental care, pain management and respiratory. Top Indoco brands include Cyclopam, Vepan, Febrex Plus, ATM, Sensodent–K, and Sensoform. Indoco has nine manufacturing facilities for formulations (Finished Dosage Forms) and active pharmaceutical ingredients (APIs) in India.
DSM Pharmaceutical Products is a Business Group of Royal DSM N.V. and is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders.